Charles Sermon
2022
In 2022, Charles Sermon earned a total compensation of $949.9K as General Counsel at Mereo BioPharma Group plc.
Compensation breakdown
| Bonus | $186,386 |
|---|---|
| Option Awards | $339,533 |
| Salary | $372,772 |
| Other | $51,198 |
| Total | $949,889 |
Sermon received $372.8K in salary, accounting for 39% of the total pay in 2022.
Sermon also received $186.4K in bonus, $339.5K in option awards and $51.2K in other compensation.
Rankings
In 2022, Charles Sermon's compensation ranked 3,142nd out of 5,760 executives tracked by ExecPay. In other words, Sermon earned more than 45.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,142 out of 5,760 | 46th |
Division Manufacturing | 1,764 out of 3,136 | 44th |
Major group Chemicals And Allied Products | 831 out of 1,422 | 42nd |
Industry group Drugs | 775 out of 1,323 | 41st |
Industry Pharmaceutical Preparations | 565 out of 969 | 42nd |
Source: SEC filing on April 24, 2024.
Sermon's colleagues
We found two more compensation records of executives who worked with Charles Sermon at Mereo BioPharma Group plc in 2022.